Results: 1-22 |
Results: 22
A RAPID PCR FIDELITY ASSAY
Authors: FLAMAN JM FREBOURG T MOREAU V CHARBONNIER F MARTIN C ISHIOKA C FRIEND SH IGGO R
Citation: Jm. Flaman et al., A RAPID PCR FIDELITY ASSAY, Nucleic acids research, 22(15), 1994, pp. 3259-3260
AUTOREGULATION OF EXPRESSION OF THE YEAST DBP2P DEAD-BOX PROTEIN IS MEDIATED BY SEQUENCES IN THE CONSERVED DBP2 INTRON
Authors: BARTA I IGGO R
Citation: I. Barta et R. Iggo, AUTOREGULATION OF EXPRESSION OF THE YEAST DBP2P DEAD-BOX PROTEIN IS MEDIATED BY SEQUENCES IN THE CONSERVED DBP2 INTRON, EMBO journal, 14(15), 1995, pp. 3800-3808
CYTOTOXIC T-LYMPHOCYTE RESPONSES TO WILD-TYPE AND MUTANT MOUSE P53 PEPTIDES
Authors: BERTHOLET S IGGO R CORRADIN G
Citation: S. Bertholet et al., CYTOTOXIC T-LYMPHOCYTE RESPONSES TO WILD-TYPE AND MUTANT MOUSE P53 PEPTIDES, European Journal of Immunology, 27(3), 1997, pp. 798-801
DETERMINING MUTATIONAL FINGERPRINTS AT THE HUMAN P53 LOCUS WITH A YEAST FUNCTIONAL ASSAY - A NEW TOOL FOR MOLECULAR EPIDEMIOLOGY
Authors: INGA A IANNONE R MONTI P MOLINA F BOLOGNESI M ABBONDANDOLO A IGGO R FRONZA G
Citation: A. Inga et al., DETERMINING MUTATIONAL FINGERPRINTS AT THE HUMAN P53 LOCUS WITH A YEAST FUNCTIONAL ASSAY - A NEW TOOL FOR MOLECULAR EPIDEMIOLOGY, Oncogene, 14(11), 1997, pp. 1307-1313
DEVELOPMENT OF NEW FUNCTIONAL ASSAYS IN YEAST FOR THE TRANSCRIPTIONALANALYSIS OF THE P53 TUMOR-SUPPRESSOR GENE
Authors: FREBOURG T LENGLET S IGGO R FLAMAN JM
Citation: T. Frebourg et al., DEVELOPMENT OF NEW FUNCTIONAL ASSAYS IN YEAST FOR THE TRANSCRIPTIONALANALYSIS OF THE P53 TUMOR-SUPPRESSOR GENE, American journal of human genetics, 61(4), 1997, pp. 352-352
FIELD CANCERIZATION AND POLYCLONAL P53 MUTATION IN THE UPPER AERODIGESTIVE TRACT
Authors: WARIDEL F ESTREICHER A BRON L FLAMAN JM FONTOLLIET C MONNIER P FREBOURG T IGGO R
Citation: F. Waridel et al., FIELD CANCERIZATION AND POLYCLONAL P53 MUTATION IN THE UPPER AERODIGESTIVE TRACT, Oncogene, 14(2), 1997, pp. 163-169
GERM-CELL TUMORS OF THE TESTIS OVEREXPRESS WILD-TYPE P53
Authors: GUILLOU L ESTREICHER A CHAUBERT P HURLIMANN J KURT AM METTHEZ G IGGO R GRAY AC JICHLINSKI P BENHATTAR J
Citation: L. Guillou et al., GERM-CELL TUMORS OF THE TESTIS OVEREXPRESS WILD-TYPE P53, The American journal of pathology, 149(4), 1996, pp. 1221-1228
HIGH-FREQUENCY OF P53 MUTATIONS IN HUMAN ORAL EPITHELIAL DYSPLASIA AND PRIMARY SQUAMOUS-CELL CARCINOMA DETECTED BY YEAST FUNCTIONAL ASSAY
Authors: KASHIWAZAKI H TONOKI H TADA M CHIBA I SHINDOH M TOTSUKA Y IGGO R MORIUCHI T
Citation: H. Kashiwazaki et al., HIGH-FREQUENCY OF P53 MUTATIONS IN HUMAN ORAL EPITHELIAL DYSPLASIA AND PRIMARY SQUAMOUS-CELL CARCINOMA DETECTED BY YEAST FUNCTIONAL ASSAY, Oncogene, 15(22), 1997, pp. 2667-2674
HOMOZYGOUS P53 GENE MUTATION IN A RADIATION-INDUCED GLIOBLASTOMA 10 YEARS AFTER TREATMENT FOR AN INTRACRANIAL GERM-CELL TUMOR - CASE-REPORT
Authors: TADA M SAWAMURA Y ABE H IGGO R
Citation: M. Tada et al., HOMOZYGOUS P53 GENE MUTATION IN A RADIATION-INDUCED GLIOBLASTOMA 10 YEARS AFTER TREATMENT FOR AN INTRACRANIAL GERM-CELL TUMOR - CASE-REPORT, Neurosurgery, 40(2), 1997, pp. 393-396
IDENTIFICATION OF CLONAL MUTATIONS IN MORPHOLOGICALLY NORMAL MUCOSA OF THE AERODIGESTIVE TRACT
Authors: WARIDEL F IGGO R
Citation: F. Waridel et R. Iggo, IDENTIFICATION OF CLONAL MUTATIONS IN MORPHOLOGICALLY NORMAL MUCOSA OF THE AERODIGESTIVE TRACT, European journal of cancer prevention, 5, 1996, pp. 67-73
IDENTIFICATION OF HUMAN P53 MUTATIONS WITH DIFFERENTIAL-EFFECTS ON THE BAX AND P21 PROMOTERS USING FUNCTIONAL ASSAYS IN YEAST
Authors: FLAMAN JM ROBERT V LENGLET S MOREAU V IGGO R FREBOURG T
Citation: Jm. Flaman et al., IDENTIFICATION OF HUMAN P53 MUTATIONS WITH DIFFERENTIAL-EFFECTS ON THE BAX AND P21 PROMOTERS USING FUNCTIONAL ASSAYS IN YEAST, Oncogene, 16(10), 1998, pp. 1369-1372
INHIBITION OF NONSENSE-MEDIATED MESSENGER-RNA DECAY IN CLINICAL-SAMPLES FACILITATES DETECTION OF HUMAN MSH2 MUTATIONS WITH AN IN-VIVO FUSION PROTEIN ASSAY AND CONVENTIONAL TECHNIQUES
Authors: ANDREUTTIZAUGG C SCOTT RJ IGGO R
Citation: C. Andreuttizaugg et al., INHIBITION OF NONSENSE-MEDIATED MESSENGER-RNA DECAY IN CLINICAL-SAMPLES FACILITATES DETECTION OF HUMAN MSH2 MUTATIONS WITH AN IN-VIVO FUSION PROTEIN ASSAY AND CONVENTIONAL TECHNIQUES, Cancer research, 57(15), 1997, pp. 3288-3293
INVERSE CORRELATION BETWEEN RER(-CANCER CELL-LINES() STATUS AND P53 MUTATION IN COLORECTAL)
Authors: COTTU PH MUZEAU F ESTREICHER A FLEJOU JF IGGO R THOMAS G HAMELIN R
Citation: Ph. Cottu et al., INVERSE CORRELATION BETWEEN RER(-CANCER CELL-LINES() STATUS AND P53 MUTATION IN COLORECTAL), Oncogene, 13(12), 1996, pp. 2727-2730
MUTATION OF CONSERVED DOMAIN-II ALTERS THE SEQUENCE SPECIFICITY OF DNA-BINDING BY THE P53 PROTEIN
Authors: FREEMAN J SCHMIDT S SCHARER E IGGO R
Citation: J. Freeman et al., MUTATION OF CONSERVED DOMAIN-II ALTERS THE SEQUENCE SPECIFICITY OF DNA-BINDING BY THE P53 PROTEIN, EMBO journal, 13(22), 1994, pp. 5393-5400
OVERCOMING COMPLEXITIES IN GENETIC SCREENING FOR CANCER SUSCEPTIBILITY
Authors: FRIEND SH IGGO R ISHIOKA C FITZGERALD M HOOVER I ONEILL E FREBOURG T
Citation: Sh. Friend et al., OVERCOMING COMPLEXITIES IN GENETIC SCREENING FOR CANCER SUSCEPTIBILITY, Cold Spring Harbor Symposia on Quantitative Biology, 59, 1994, pp. 673-676
REGULATION OF SPECIFIC DNA-BINDING BY P53 - EVIDENCE FOR A ROLE FOR O-GLYCOSYLATION AND CHARGED RESIDUES AT THE CARBOXY-TERMINUS
Authors: SHAW P FREEMAN J BOVEY R IGGO R
Citation: P. Shaw et al., REGULATION OF SPECIFIC DNA-BINDING BY P53 - EVIDENCE FOR A ROLE FOR O-GLYCOSYLATION AND CHARGED RESIDUES AT THE CARBOXY-TERMINUS, Oncogene, 12(4), 1996, pp. 921-930
RETROVIRUS-MEDIATED P53 GENE-THERAPY
Authors: ESTREICHER A IGGO R
Citation: A. Estreicher et R. Iggo, RETROVIRUS-MEDIATED P53 GENE-THERAPY, Nature medicine, 2(11), 1996, pp. 1163-1163
SCREENING PATIENTS FOR HETEROZYGOUS-P53 MUTATIONS USING A FUNCTIONAL ASSAY IN YEAST
Authors: ISHIOKA C FREBOURG T YAN YX VIDAL M FRIEND SH SCHMIDT S IGGO R
Citation: C. Ishioka et al., SCREENING PATIENTS FOR HETEROZYGOUS-P53 MUTATIONS USING A FUNCTIONAL ASSAY IN YEAST, Nature genetics, 5(2), 1993, pp. 124-129
SIGNIFICANT CORRELATION OF NITRIC-OXIDE SYNTHASE ACTIVITY AND P53 GENE MUTATION IN STAGE-I LUNG ADENOCARCINOMA
Authors: FUJIMOTO H SASAKI J MATSUMOTO M SUGA M ANDO Y IGGO R TADA M SAYA H ANDO M
Citation: H. Fujimoto et al., SIGNIFICANT CORRELATION OF NITRIC-OXIDE SYNTHASE ACTIVITY AND P53 GENE MUTATION IN STAGE-I LUNG ADENOCARCINOMA, Japanese journal of cancer research, 89(7), 1998, pp. 696-702
SIMPLE IDENTIFICATION OF DOMINANT P53 MUTANTS BY A YEAST FUNCTIONAL ASSAY
Authors: INGA A CRESTA S MONTI P APRILE A SCOTT G ABBONDANDOLO A IGGO R FRONZA G
Citation: A. Inga et al., SIMPLE IDENTIFICATION OF DOMINANT P53 MUTANTS BY A YEAST FUNCTIONAL ASSAY, Carcinogenesis, 18(10), 1997, pp. 2019-2021
THE HUMAN TUMOR-SUPPRESSOR GENE P53 IS ALTERNATIVELY SPLICED IN NORMAL-CELLS
Authors: FLAMAN JM WARIDEL F ESTREICHER A VANNIER A LIMACHER JM GILBERT D IGGO R FREBOURG T
Citation: Jm. Flaman et al., THE HUMAN TUMOR-SUPPRESSOR GENE P53 IS ALTERNATIVELY SPLICED IN NORMAL-CELLS, Oncogene, 12(4), 1996, pp. 813-818
USE OF TRANSCRIPTION REPORTERS WITH NOVEL P53 BINDING-SITES TO TARGETTUMOR-CELLS EXPRESSING ENDOGENOUS OR VIRALLY TRANSDUCED P53 MUTANTS WITH ALTERED SEQUENCE-SPECIFICITY
Authors: GAGNEBIN J KOVAR H KAJAVA AV ESTREICHER A JUG G MONNIER P IGGO R
Citation: J. Gagnebin et al., USE OF TRANSCRIPTION REPORTERS WITH NOVEL P53 BINDING-SITES TO TARGETTUMOR-CELLS EXPRESSING ENDOGENOUS OR VIRALLY TRANSDUCED P53 MUTANTS WITH ALTERED SEQUENCE-SPECIFICITY, Oncogene, 16(5), 1998, pp. 685-690
Risultati: 1-22 |